Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes

被引:1
|
作者
Mittendorff, Claudia [1 ]
Abu-Taha, Issam [1 ]
Kassler, Lena [1 ]
Hustedt, Tobias [2 ,3 ]
Wolf, Stephanie [2 ,3 ]
Bode, Johannes G. [2 ,3 ]
Kamler, Markus [4 ]
Dobrev, Dobromir [1 ,5 ,6 ,7 ,8 ]
Fender, Anke C. [1 ]
机构
[1] Univ Duisburg Essen, Inst Pharmacol, West German Heart & Vasc Ctr, Duisburg, Germany
[2] Heinrich Heine Univ, Fac Med, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany
[3] Heinrich Heine Univ, Dusseldorf Univ Hosp, Dusseldorf, Germany
[4] Univ Hosp Essen, Dept Thorac & Cardiovasc Surg, Essen, Germany
[5] Montreal Heart Inst, Dept Med, Montreal, PQ, Canada
[6] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada
[7] Univ Montreal, Montreal, PQ, Canada
[8] Baylor Coll Med, Dept Integrat Physiol, Houston, TX USA
基金
美国国家卫生研究院;
关键词
Atrial; Cardiomyocyte; C-met; NLRP3; inflammasome; Protease-activated receptor; Thrombin; EXPRESSION; TARGET; CELLS;
D O I
10.1007/s00210-024-03436-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Thrombin supports coagulation-independent inflammation via protease-activated receptors (PAR). PAR4 is specifically increased in obese human atria, correlating with NLRP3 inflammasome activation. PAR4-mediated NLRP3 inflammasome activation in atrial cardiomyocytes is not known, nor have signaling partners been identified. Thrombin transactivates the hepatocyte growth factor receptor in some cancer cells, so we examined PAR4/c-met cross-talk in atrial cardiomyocytes and its possible significance in obesity. Cardiomyocytes from right atrial appendages (RAA) of obese patients expressed more PAR1 and PAR4 compared to non-obese. In HL-1 atrial cardiomyocytes, thrombin induced caspase-1 auto-activation and IL-1 beta maturation; IL-1 beta secretion was evoked by PAR4-activating peptide (AP), but not PAR1-AP. PAR4-AP additionally increased phosphorylated CaMKII-Thr287, mTOR-Ser2481, and Akt-Ser473 while suppressing AMPK-Thr172 phosphorylation. Total kinase levels were largely unaltered. PAR4AP rapidly increased phosphorylated c-met in HL-1 cells and over time also transcriptionally upregulated c-met. The c-met inhibitor SGX-523 abrogated the effects of PAR4-AP on CaMKII/AKT/mTOR phosphorylation but did not affect PAR4-stimulated IL-1 beta production. Obese human RAA contained more IL-1 beta, phospho-c-met, and phospho-mTOR than non-obese RAA; CamKII phosphorylation was not modified. Atria from high-fat diet (HFD) versus chow-fed mice also contained more IL-1 beta, together with higher myeloperoxidase activity, Acta2 mRNA total and phosphorylated c-met; these increases were blunted in PAR4-/- HFD-fed mice. Thrombin cross-activates c-met via PAR4 in atrial cardiomyocytes. Transactivated c-met contributes partially to PAR4-mediated signaling, but NLRP3 inflammasome activation appears to be largely independent of c-met. Abundance of PAR4 and activated c-met increases with obesity, providing therapeutic targets for management of adiposity-driven AF.
引用
收藏
页码:2783 / 2796
页数:14
相关论文
共 50 条
  • [41] KRC-327, a selective novel inhibitor of c-Met receptor tyrosine kinase with anticancer activity
    Park, Byung Hee
    Jung, Kyung Hee
    Yun, Sun-Mi
    Hong, Sang-Won
    Ryu, Jae Wook
    Jung, Heejung
    Ha, Jae Du
    Lee, Jongkook
    Hong, Soon-Sun
    CANCER LETTERS, 2013, 331 (02) : 158 - 166
  • [42] Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas
    Cruz, J
    Reis-Filho, JS
    Silva, P
    Lopes, JM
    ONCOLOGY, 2003, 65 (01) : 72 - 82
  • [43] ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
    Munshi, Neru
    Jeay, Sebastien
    Li, Youzhi
    Chen, Chang-Rung
    France, Dennis S.
    Ashwell, Mark A.
    Hill, Jason
    Moussa, Magdi M.
    Leggett, David S.
    Li, Chiang J.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (06) : 1544 - 1553
  • [44] Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis
    Weidner, KM
    DiCesare, S
    Sachs, M
    Brinkmann, V
    Behrens, J
    Birchmeier, W
    NATURE, 1996, 384 (6605) : 173 - 176
  • [45] Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma
    R. Akhavan-Sigari
    M. Abili
    M. R. Gaab
    V. Rohde
    N. Zafar
    P. Emami
    H. Ostertag
    Neurosurgical Review, 2015, 38 : 89 - 99
  • [46] Immunohistochemical (IHC) expression of c-Met receptor tyrosine kinase (c-Met) has prognostic significance and its activation is related to phosphorylated protein kinase c β (p-PKC β) in malignant mesothelioma (MM)
    Westerhoff, M.
    Faoro, L.
    Loganathan, S.
    Salgia, R.
    Krausz, T.
    Husain, A. N.
    LABORATORY INVESTIGATION, 2008, 88 : 353A - 353A
  • [47] Immunohistochemical (IHC) expression of c-Met receptor tyrosine kinase (c-Met) has prognostic significance and its activation is related to phosphorylated protein kinase cβ (p-PKCβ) in malignant mesothelioma (MM)
    Westerhoff, M.
    Faoro, L.
    Loganathan, S.
    Salgia, R.
    Krausz, T.
    Husain, A. N.
    MODERN PATHOLOGY, 2008, 21 : 353A - 353A
  • [48] Down-regulation of the receptor tyrosine kinase c-Met inhibits invasion and adhesion of ovarian cancer cells
    Sawada, Kenjiro
    Radjabi, A. Reza
    Vande Woude, George
    Shinomiya, Nariyoshi
    Yamada, Seiko Diane
    Lengyel, Ernst
    CANCER RESEARCH, 2006, 66 (08)
  • [49] Enzymatic Characterization of c-Met Receptor Tyrosine Kinase Oncogenic Mutants and Kinetic Studies with Aminopyridine and Triazolopyrazine Inhibitors
    Timofeevski, Sergei L.
    McTigue, Michele A.
    Ryan, Kevin
    Cui, Jean
    Zou, Helen Y.
    Zhu, Jeff X.
    Chau, Fannie
    Alton, Gordon
    Karlicek, Shannon
    Christensen, James G.
    Murray, Brion W.
    BIOCHEMISTRY, 2009, 48 (23) : 5339 - 5349
  • [50] Synaptic enrichment and regulation of neocortical synaptogenesis via the C-MET receptor tyrosine kinase, an autism risk gene
    Eagleson, K. L.
    Levitt, P.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2015, 47 : 77 - 78